Equity Overview
Price & Market Data
Price: $7.50
Daily Change: +$0.25 / 3.33%
Daily Range: $7.35 - $7.58
Market Cap: $297,446,240
Daily Volume: 47,837
Performance Metrics
1 Week: 0.54%
1 Month: -3.23%
3 Months: 18.67%
6 Months: -31.76%
1 Year: -5.48%
YTD: -6.25%
Company Details
Employees: 183
Sector: Health technology
Industry: Medical specialties
Country:
Details
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.